Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress

[1] Diabetes [World Health Organization webpage]. Available at https://www.who.int/health-topics/diabetes#tab=tab_1 (Accessed September 2020). Diabetes [World Health Organization webpage] Available at https://www.who.int/health-topics/diabetes#tab=tab_1 (Accessed September 2020). Search in Google Scholar

[2] Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018; 27: 740–756. DruckerDJ Mechanisms of action and therapeutic application of glucagon-like peptide-1 Cell Metab. 2018 27 740 756 10.1016/j.cmet.2018.03.00129617641 Search in Google Scholar

[3] Dardano A, Miccoli R, Bianchi C, Daniele G, Del Prato S. Invited review. Series: Implicaions of the recent CVOTs in type 2 diabetes: Which patients for GLP-1RA or SGLT-2 inhibitor? Diabetes Res. Clin. Pract. 2020; 162: 108112. DardanoA MiccoliR BianchiC DanieleG Del PratoS Invited review. Series: Implicaions of the recent CVOTs in type 2 diabetes: Which patients for GLP-1RA or SGLT-2 inhibitor? Diabetes Res. Clin. Pract. 2020 162 108112 10.1016/j.diabres.2020.10811232198123 Search in Google Scholar

[4] Juang JH, Kuo CH, Wu CH, Juang C. Exendin-4 treatment expands graft β-cell mass in diabetic mice transplanted with a marginal number of fresh islets. Cell Transplant. 2008; 17: 641–647. JuangJH KuoCH WuCH JuangC Exendin-4 treatment expands graft β-cell mass in diabetic mice transplanted with a marginal number of fresh islets Cell Transplant. 2008 17 641 647 10.3727/09636890878609276618819252 Search in Google Scholar

[5] Miki A, Ricordi C, Sakuma Y, Yamamoto T, Misawa R, Mita A, Molano RD, Vaziri ND, Pileggi A, Ichii H. Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation. PLoS. One. 2018; 13: e0196570. MikiA RicordiC SakumaY YamamotoT MisawaR MitaA MolanoRD VaziriND PileggiA IchiiH Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation PLoS. One. 2018 13 e0196570 10.1371/journal.pone.0196570593377829723228 Search in Google Scholar

[6] Bułdak Ł, Machnik G, Bułdak RJ, Łabuzek K, Bołdys A, Belowski D, Basiak M, Okopień B: Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner. Pharmacol. Rep. 2016; 68: 329–337. BułdakŁ MachnikG BułdakRJ ŁabuzekK BołdysA BelowskiD BasiakM OkopieńB Exenatide (a GLP-1 agonist) expresses anti-inflammatory properties in cultured human monocytes/macrophages in a protein kinase A and B/Akt manner Pharmacol. Rep. 2016 68 329 337 10.1016/j.pharep.2015.10.00826922535 Search in Google Scholar

[7] Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y: Oxidative stress and diabetes: Antioxidative strategies. Front Med. 2020; 14: 583–600. ZhangP LiT WuX NiceEC HuangC ZhangY Oxidative stress and diabetes: Antioxidative strategies Front Med. 2020 14 583 600 10.1007/s11684-019-0729-132248333 Search in Google Scholar

[8] Bułdak RJ, Bułdak Ł, Kukla M, Gabriel A, Zwirska-Korczala K. Significance of selected antioxidant enzymes in cancer cell progression. Pol. J. Pathol. 2014; 65: 167–175. BułdakRJ BułdakŁ KuklaM GabrielA Zwirska-KorczalaK Significance of selected antioxidant enzymes in cancer cell progression Pol. J. Pathol. 2014 65 167 175 10.5114/pjp.2014.4577925372413 Search in Google Scholar

[9] Kondo M, Tanabe K, Amo-Shiinoki K, Hatanaka M, Morii T, Takahashi H, Seino S, Yamada Y, Tanizawa Y. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia. 2018; 61: 2189–2201. KondoM TanabeK Amo-ShiinokiK HatanakaM MoriiT TakahashiH SeinoS YamadaY TanizawaY Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome Diabetologia. 2018 61 2189 2201 10.1007/s00125-018-4679-y30054673 Search in Google Scholar

[10] Yang SH, Xu RX, Cui CJ, Wang Y, Du Y, Chen ZG, Yao YH, Ma CY, Zhu CG, Guo YL, et al. Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism. Cardiovasc. Diabetol. 2018; 17: 48. YangSH XuRX CuiCJ WangY DuY ChenZG YaoYH MaCY ZhuCG GuoYL Liraglutide downregulates hepatic LDL receptor and PCSK9 expression in HepG2 cells and db/db mice through a HNF-1a dependent mechanism Cardiovasc. Diabetol. 2018 17 48 10.1186/s12933-018-0689-9588540829618348 Search in Google Scholar

[11] Perego C, Da Dalt L, Pirillo A, Galli A, Catapano AL, Norata GD. Cholesterol metabolism, pancreatic β-cell function and diabetes. Biochim. Biophys. Acta Mol. Basis Dis. 2019; 1865: 2149–2156. PeregoC Da DaltL PirilloA GalliA CatapanoAL NorataGD Cholesterol metabolism, pancreatic β-cell function and diabetes Biochim. Biophys. Acta Mol. Basis Dis. 2019 1865 2149 2156 10.1016/j.bbadis.2019.04.01231029825 Search in Google Scholar

[12] Ramin-Mangata S, Blanchard V, Lambert G. Key aspects of PCSK9 inhibition beyond LDL lowering. Curr. Opin. Lipidol. 2018; 29: 453–458. Ramin-MangataS BlanchardV LambertG Key aspects of PCSK9 inhibition beyond LDL lowering Curr. Opin. Lipidol. 2018 29 453 458 10.1097/MOL.000000000000055130199407 Search in Google Scholar

[13] Abramoff MD, Magalhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Inter. 2004; 11: 36–42. AbramoffMD MagalhaesPJ RamSJ Image processing with ImageJ Biophotonics Inter. 2004 11 36 42 Search in Google Scholar

[14] Zhang H, Forman HJ. Acrolein induces heme oxygenase-1 through PKC-delta and PI3K in human bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 2008; 38: 483–490. ZhangH FormanHJ Acrolein induces heme oxygenase-1 through PKC-delta and PI3K in human bronchial epithelial cells Am. J. Respir. Cell. Mol. Biol. 2008 38 483 490 10.1165/rcmb.2007-0260OC18048804 Search in Google Scholar

[15] Kajimoto Y, Kaneto H. Role of oxidative stress in pancreatic β-cell dysfunction. Ann. N.Y. Acad. Sci. 2004; 1011: 168–176. KajimotoY KanetoH Role of oxidative stress in pancreatic β-cell dysfunction Ann. N.Y. Acad. Sci. 2004 1011 168 176 10.1007/978-3-662-41088-2_1715126294 Search in Google Scholar

[16] Yap MK, Misuan N.: Exendin-4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant. Basic Clin. Pharmacol. Toxicol. 2019; 124: 513–527. YapMK MisuanN. Exendin-4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant Basic Clin. Pharmacol. Toxicol. 2019 124 513 527 10.1111/bcpt.1316930417596 Search in Google Scholar

[17] Bułdak Ł, Machnik G, Skudrzyk E, Bołdys A, Okopień B. The impact of exenatide (a GLP-1 agonist) on markers of inflammation and oxidative stress in normal human astrocytes subjected to various glycemic conditions. Exp. Ther. Med. 2019; 17: 2861–2869. BułdakŁ MachnikG SkudrzykE BołdysA OkopieńB The impact of exenatide (a GLP-1 agonist) on markers of inflammation and oxidative stress in normal human astrocytes subjected to various glycemic conditions Exp. Ther. Med. 2019 17 2861 2869 10.3892/etm.2019.7245642522730906473 Search in Google Scholar

[18] Alnahdi A, John A, Raza H. N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose/high palmitic acid treatment in pancreatic Rin-5F cells. PLoS. One. 2019; 14: e0226696. AlnahdiA JohnA RazaH N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose/high palmitic acid treatment in pancreatic Rin-5F cells PLoS. One. 2019 14 e0226696 10.1371/journal.pone.0226696692467931860682 Search in Google Scholar

[19] Newsholme P, Keane KN, Carlessi R, Cruzat V. Oxidative stress pathways in pancreatic β-cells and insulin-sensitive cells and tissues: Importance to cell metabolism, function, and dysfunction. Am. J. Physiol. Cell Physiol. 2019; 317: C420–C433. NewsholmeP KeaneKN CarlessiR CruzatV Oxidative stress pathways in pancreatic β-cells and insulin-sensitive cells and tissues: Importance to cell metabolism, function, and dysfunction Am. J. Physiol. Cell Physiol. 2019 317 C420 C433 10.1152/ajpcell.00141.201931216193 Search in Google Scholar

[20] Rocha S, Gomes D, Lima M, Bronze-da-Rocha E, Santos-Silva A. Peroxiredoxin 2, glutathione peroxidase, and catalase in the cytosol and membrane of erythrocytes under H₂O₂-induced oxidative stress. Free Radic. Res. 2015; 49: 990–1003. RochaS GomesD LimaM Bronze-da-RochaE Santos-SilvaA Peroxiredoxin 2, glutathione peroxidase, and catalase in the cytosol and membrane of erythrocytes under H₂O₂-induced oxidative stress Free Radic. Res. 2015 49 990 1003 10.3109/10715762.2015.102840225786472 Search in Google Scholar

[21] Bułdak Ł, Łabuzek K, Bułdak RJ, Machnik G, Bołdys A, Okopień B. Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages. Naunyn Schmiedebergs Arch. Pharmacol. 2015; 388: 905–919. BułdakŁ ŁabuzekK BułdakRJ MachnikG BołdysA OkopieńB Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages Naunyn Schmiedebergs Arch. Pharmacol. 2015 388 905 919 10.1007/s00210-015-1124-3453750725980358 Search in Google Scholar

[22] Vasu S, McClenaghan NH, McCluskey JT, Flatt PR. Cellular responses of novel human pancreatic β-cell line, 1.1B4 to hyperglycemia. Islets. 2013; 5: 170–177. VasuS McClenaghanNH McCluskeyJT FlattPR Cellular responses of novel human pancreatic β-cell line, 1.1B4 to hyperglycemia Islets. 2013 5 170 177 10.4161/isl.2618423985558 Search in Google Scholar

[23] Kim MH, Kim EH, Jung HS, Yang D, Park EY, Jun HS. EX4 stabilizes and activates Nrf2 via PKC, contributing to the prevention of oxidative stress-induced pancreatic beta cell damage. Toxicol. Appl. Pharmacol. 2017; 315: 60–69. KimMH KimEH JungHS YangD ParkEY JunHS EX4 stabilizes and activates Nrf2 via PKC, contributing to the prevention of oxidative stress-induced pancreatic beta cell damage Toxicol. Appl. Pharmacol. 2017 315 60 69 10.1016/j.taap.2016.12.00527939242 Search in Google Scholar

[24] Kim JY, Lim DM, Moon CI, Jo KJ, Lee SK, Baik HW, Lee KH, Lee KW, Park KY, Kim BJ. Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3 activity. J. Korean Med. Sci. 2010; 25: 1626–1632. KimJY LimDM MoonCI JoKJ LeeSK BaikHW LeeKH LeeKW ParkKY KimBJ Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3 activity J. Korean Med. Sci. 2010 25 1626 1632 10.3346/jkms.2010.25.11.1626296700021060752 Search in Google Scholar

[25] Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 2010; 106: 1319–1331. GeraldesP KingGL Activation of protein kinase C isoforms and its impact on diabetic complications Circ. Res. 2010 106 1319 1331 10.1161/CIRCRESAHA.110.217117287759120431074 Search in Google Scholar

[26] Zhang L, Tian J, Diao S, Zhang G, Xiao M, Chang D. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction. Chem. Biol. Interact. 2020; 332: 109252. ZhangL TianJ DiaoS ZhangG XiaoM ChangD GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction Chem. Biol. Interact. 2020 332 109252 10.1016/j.cbi.2020.10925232898504 Search in Google Scholar

[27] Ooba N, Setoguchi S, Sato T, Kubota K. Lipid-lowering drugs and risk of new-onset diabetes: A cohort study using Japanese healthcare data linked to clinical data for health screening. BMJ Open. 2017; 7: e015935. OobaN SetoguchiS SatoT KubotaK Lipid-lowering drugs and risk of new-onset diabetes: A cohort study using Japanese healthcare data linked to clinical data for health screening BMJ Open. 2017 7 e015935 10.1136/bmjopen-2017-015935572609428667223 Search in Google Scholar

[28] Aoki K, Kamiyama H, Takihata M, Taguri M, Shibata E, Shinoda K, Yoshii T, Nakajima S, Terauchi Y. Effect of liraglutide on lipids in patients with type 2 diabetes: A pilot study. Endocr. J. 2020; 67: 957–962. AokiK KamiyamaH TakihataM TaguriM ShibataE ShinodaK YoshiiT NakajimaS TerauchiY Effect of liraglutide on lipids in patients with type 2 diabetes: A pilot study Endocr. J. 2020 67 957 962 10.1507/endocrj.EJ19-046432554954 Search in Google Scholar

[29] Roehrich ME, Mooser V, Lenain V, Herz J, Nimpf J, Azhar S, Bideau M, Capponi A, Nicod P, Haefliger JA, Waeber G. Insulin-secreting β-cell dysfunction induced by human lipoproteins. J. Biol. Chem. 2003; 278: 18368–18375. RoehrichME MooserV LenainV HerzJ NimpfJ AzharS BideauM CapponiA NicodP HaefligerJA WaeberG Insulin-secreting β-cell dysfunction induced by human lipoproteins J. Biol. Chem. 2003 278 18368 18375 10.1074/jbc.M30010220012594227 Search in Google Scholar

[30] Kockx M, Kritharides L. Pancreatic PCSK9 and its involvement in diabetes. J. Thorac. Dis. 2019; 11: S2018–S2022. KockxM KritharidesL Pancreatic PCSK9 and its involvement in diabetes J. Thorac. Dis. 2019 11 S2018 S2022 10.21037/jtd.2019.06.37678377731632814 Search in Google Scholar